Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation

Supportive Care in Cancer

Volumn 10, Issue 1, 2002, Pages 71-75

  Jatoi, Aminah ^a   Yamashita, Jun ichi ^b   Sloan, Jeff A ^a   Novotny, Paul J ^a   Windschitl, Harold E ^c   Loprinzi, Charles L ^a  

^a MAYO CLINIC   (United States)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c CentraCare Clinic   (United States)

Author keywords

Advanced cancer; Anorexia; Megestrol acetate; Weight loss

Indexed keywords

CYTOKINE; DRONABINOL; INTERLEUKIN 6; MEGESTROL ACETATE; PLACEBO;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; STATISTICAL SIGNIFICANCE; SUSPENSION; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANOREXIA; ANTINEOPLASTIC AGENTS, HORMONAL; DOWN-REGULATION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MEGESTROL ACETATE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; TETRAHYDROCANNABINOL; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0036941020     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-001-0310-7     Document Type: Article

References (15)

1. Agteresch HJ, Dagnelie PC, van der Gaast A, Stijnen T, Wilson JH (2000) Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 92:321-328
2. Bruera E, Macmillan K, Kuehan N, et al (1990) A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279-1282
3. Finck BN, Johnson RW (1997) Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1 beta in the rat. Brain Res 761:333-337
4. Klein TW, Lane B, Newton CA, Friedman H (2000) The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 225:1-8
5. Mantovani G, Maccio A, Esu S, et al (1997) Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur J Cancer 33:602-607
6. Yamashita J, Hideshima T, Shirakusa T, Ogawa M (1996) Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast cancer. Cancer 78:2346-2352
7. Kurzrock R, Redman J, Cabanillas F, et al (1993) Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease patients and with B symptoms. Cancer Res 53:2118-2122
8. Oka M, Yamamoto K, Takahashi M, et al (1996) Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous carcinoma. Cancer Res 56:2776-2780
9. Schmoll E, Wilke H, Thole R, et al (1991) Megestrol acetate in cancer cachexia. Semin Oncol 18:32-34
10. Scott HR, McMillan DC, Crilly A, McArdle CS, Milroy R (1996) The relationship between weight loss and interleukin 6 in non-small cell lung cancer. Br J Cancer 73:1560-1562
11. Smith MS, Yamamoto, Newton C, Friedman H, Kelin T (1997) Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila. Proc Soc Exp Biol Med 214:69-75
12. Strassman G, Fong M, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89:1681-1684
13. Tchekmedyian NS, Hickman M, Siau J, et al (1992) Megestrol acetate in cancer anorexia and weight loss. Cancer 69:1268-1274
14. Yanagawa H, Sone S, Takahashi Y, et al (1995) Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer 71:1095-1098
15. Loprinzi CL, Ellison NM, Schaid DJ, et al (1990) Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82:1127-1132